Damage from reactive free species (ROS), including free radicals, occurs in brains of patients with Alzheimer's Disease (AD) studied at autopsy. Whether abnormal oxidative processes are inherent properties of AD cells that promote the pathology or are secondary to neurodegeneration is unknown. The answer will have important therapeutic implications. For several reasons, the best system in which to test whether AD cells have an inherent altered ability to handle oxidative stress is cultured fibroblasts from AD patients and appropriate controls. The use of these cells enables testing for the effects of AD-related genetic mutations on dynamic processes in cells that have the same genetic background in which the disease is expressed. AD/control differences in cultured cells reflect inherent properties of these cells (i.e., the observed differences are not secondary to neurodegeneration, diet or drugs). Our studies with fibroblast cell lines from multiple individuals bearing a particular presenilin-1 AD mutation reveal abnormal ROS metabolism in AD cells supporting the possibility that abnormal ROS are part of the cellular response in AD, rather than a non- specific consequence of neurodegeneration. Fibroblasts from transgenic mice bearing AD-causing mutations will be used to test whether AD-causing mutations affect human and mouse fibroblasts similarly, and if changes in fibroblasts are predictive of changes in brain. The proposed experiments will test the following three component hypothesis: (1) Cells from AD patients handle oxidative stress differently than control cells. (2) the nature of the abnormality in ROS metabolism varies between groups bearing different AD- causing gene mutations in presenilin. (3) Abnormalities in ROS metabolism underlie previously reported AD related changes in calcium homeostasis, mitochondrial function and amyloid-beta- peptide production in fibroblasts. Evidence in favor of this hypothesis would imply that different AD gene-defect groups will best respond to specific types of antioxidants, and that the appropriate antioxidant therapy for a particular patient could be determined in studies of cultured cells from that patient.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
2R01AG011921-04A2
Application #
6193217
Study Section
Medical Biochemistry Study Section (MEDB)
Program Officer
Snyder, D Stephen
Project Start
1996-02-20
Project End
2004-06-30
Budget Start
2000-08-01
Budget End
2001-06-30
Support Year
4
Fiscal Year
2000
Total Cost
$266,175
Indirect Cost
Name
Winifred Masterson Burke Med Research Institute
Department
Type
DUNS #
780676131
City
White Plains
State
NY
Country
United States
Zip Code
10605
Gibson, Gary E; Hirsch, Joseph A; Fonzetti, Pasquale et al. (2016) Vitamin B1 (thiamine) and dementia. Ann N Y Acad Sci 1367:21-30
Bubber, P; Hartounian, V; Gibson, G E et al. (2011) Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients. Eur Neuropsychopharmacol 21:254-60
Karuppagounder, Saravanan S; Xu, Hui; Shi, Qingli et al. (2009) Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model. Neurobiol Aging 30:1587-600
Shi, Qingli; Risa, Øystein; Sonnewald, Ursula et al. (2009) Mild reduction in the activity of the alpha-ketoglutarate dehydrogenase complex elevates GABA shunt and glycolysis. J Neurochem 109 Suppl 1:214-21
Gibson, Gary E; Karuppagounder, Saravanan S; Shi, Qingli (2008) Oxidant-induced changes in mitochondria and calcium dynamics in the pathophysiology of Alzheimer's disease. Ann N Y Acad Sci 1147:221-32
Karuppagounder, Saravanan S; Xu, Hui; Pechman, David et al. (2008) Translocation of amyloid precursor protein C-terminal fragment(s) to the nucleus precedes neuronal death due to thiamine deficiency-induced mild impairment of oxidative metabolism. Neurochem Res 33:1365-72
Shi, Qingli; Xu, Hui; Kleinman, Wayne A et al. (2008) Novel functions of the alpha-ketoglutarate dehydrogenase complex may mediate diverse oxidant-induced changes in mitochondrial enzymes associated with Alzheimer's disease. Biochim Biophys Acta 1782:229-38
Karuppagounder, Saravanan S; Shi, Qingli; Xu, Hui et al. (2007) Changes in inflammatory processes associated with selective vulnerability following mild impairment of oxidative metabolism. Neurobiol Dis 26:353-62
Shi, Q; Karuppagounder, S S; Xu, H et al. (2007) Responses of the mitochondrial alpha-ketoglutarate dehydrogenase complex to thiamine deficiency may contribute to regional selective vulnerability. Neurochem Int 50:921-31
Waagepetersen, Helle S; Hansen, Gert H; Fenger, Kirsten et al. (2006) Cellular mitochondrial heterogeneity in cultured astrocytes as demonstrated by immunogold labeling of alpha-ketoglutarate dehydrogenase. Glia 53:225-31

Showing the most recent 10 out of 53 publications